Manidipine

CAT:
804-HY-B0419-01
Size:
50 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Manidipine - image 1

Manidipine

  • UNSPSC Description:

    Manidipine is a calcium channel blocker that is used clinically as an antihypertensive. Target: Calcium Channel Manidipine is a dihydropyridine calcium antagonist, which causes systemic vasodilation by inhibiting the voltage-dependent calcium inward currents in smooth muscle cells. Manidipine was well tolerated in clinical trials, with most adverse effects related to vasodilation [1]. Manidipine is a lipophilic, third-generation dihydropyridine calcium channel antagonist with a high degree of selectivity for the vasculature, thereby inducing marked peripheral vasodilation with negligible cardiodepression. manidipine represents a first-line treatment option for patients with essential mild-to-moderate hypertension [2]. Manidipine has neutral effects on glucose and lipid metabolism and is generally well tolerated. Manidipine thus represents a first-line option for lowering BP in patients with mild-to-moderate hypertension [3].
  • Target Antigen:

    Calcium Channel
  • Type:

    Reference compound
  • Related Pathways:

    Membrane Transporter/Ion Channel;Neuronal Signaling
  • Applications:

    Neuroscience-Neuromodulation
  • Field of Research:

    Cardiovascular Disease
  • Assay Protocol:

    https://www.medchemexpress.com/manidipine.html
  • Purity:

    99.92
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)
  • Smiles:

    O=C(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC=CC([N+]([O-])=O)=C2)OCCN3CCN(C(C4=CC=CC=C4)C5=CC=CC=C5)CC3
  • Molecular Weight:

    610.70
  • References & Citations:

    [1]Cheer, S.M. and K. McClellan, Manidipine: a review of its use in hypertension. Drugs, 2001. 61(12): p. 1777-99.|[2]McKeage, K. and L.J. Scott, Manidipine: a review of its use in the management of hypertension. Drugs, 2004. 64(17): p. 1923-40.|[3]Roca-Cusachs, A. and F. Triposkiadis, Antihypertensive effect of manidipine. Drugs, 2005. 65 Suppl 2: p. 11-9.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture)
  • Clinical Information:

    Launched
  • CAS Number:

    89226-50-6